NewSPACInsider launches AI-powered access to its SPAC databaseLearn more →

Market Intel

9 articles this week

SPAC IPO Terms Tracker: November 6, 2026

Terms Tracker for the Week Ending November 6, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. There were no IPOs priced this week, so the November monthly IPO count starts at zero, but deal announcements did the heavy lifting with five business combinations announced. More

Armada III (AACI) to Combine with Brains Bioceutical in $892M Deal

Armada III (NASDAQ:AACI) has entered into a definitive agreement to combine with drug developer Brains Bioceutical at a pro forma enterprise value of $891.8 million. Brains Bioceutical has built out the manufacturing base to provide medical-grade cannabinoid ingredients to the biotech and consumer industries while pursuing its own potential drug candidates. More